Premium
F4‐02‐02: Relapse risk after discontinuation of risperidone treatment in Alzheimer's disease
Author(s) -
Devanand Davangere,
Schultz Susan,
Mintzer Jacobo,
Sultzer David,
la Pena Danilo,
Gupta Sanjay,
Pelton Gregory,
Schimming Corbett,
Levin Bruce
Publication year - 2012
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2012.05.1630
Subject(s) - risperidone , discontinuation , placebo , antipsychotic , psychosis , hazard ratio , medicine , extrapyramidal symptoms , adverse effect , psychology , randomized controlled trial , atypical antipsychotic , psychiatry , schizophrenia (object oriented programming) , confidence interval , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom